Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Change in Accured Expenses (2022 - 2023)

Bluejay Diagnostics' Change in Accured Expenses history spans 2 years, with the latest figure at -$967215.0 for Q4 2023.

  • For Q4 2023, Change in Accured Expenses fell 752.48% year-over-year to -$967215.0; the TTM value through Dec 2023 reached -$30279.0, down 109.0%, while the annual FY2024 figure was -$695653.0, 2197.48% down from the prior year.
  • Change in Accured Expenses for Q4 2023 was -$967215.0 at Bluejay Diagnostics, down from $463956.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $487141.0 in Q2 2023 and bottomed at -$967215.0 in Q4 2023.